Literature DB >> 26070603

A novel tool for three-dimensional roadmapping reduces radiation exposure and contrast agent dose in complex endovascular interventions.

Lars Stangenberg1, Fahad Shuja1, Bart Carelsen2, Thijs Elenbaas2, Mark C Wyers1, Marc L Schermerhorn3.   

Abstract

OBJECTIVE: The volume and complexity of endovascular procedures are increasing. Multidetector computed tomography (CT) made precise three-dimensional (3D) planning of these procedures possible, but intraoperative imaging, even with the use of modern flat-panel detectors, is limited to two dimensions. Flat detectors, however, allow C-arm cone-beam CT. This technology can be used to generate a 3D data set that can be fused with a preoperative high-resolution CT scan, thus generating a live 3D roadmap. We hypothesized that use of a novel image fusion software, VesselNavigator (Philips Healthcare, Best, The Netherlands), facilitates precise and expeditious procedures and therefore reduces radiation exposure and contrast agent dose.
METHODS: A retrospective review of patients undergoing standard aortobi-iliac endovascular aneurysm repair at our institution between January 2011 and April 2014 was performed. Conventional imaging was compared with VesselNavigator-assisted imaging, and a matched analysis based on body mass index (BMI) was performed because of the dependence of radiation dose on body habitus. Outcome parameters were procedure time, fluoroscopy time, radiation, and contrast agent dose.
RESULTS: A total of 75 patients were identified. After matching based on BMI, control and VesselNavigator groups each had 16 patients with BMI of 27.0 ± 3.6 kg/m(2) and 27.0 ± 3.6 kg/m(2), respectively (mean ± standard deviation). R(2) was 6.37 × 10(-7). Radiation dose measured as air kerma was lower with VesselNavigator (1067 ± 470.4 mGy vs 1768 ± 696.2 mGy; P = .004). Fluoroscopy time was shorter (18.4 ± 6.8 minutes vs 26.8 ± 10.0 minutes; P = .01) and contrast agent dose was lower (37.4 ± 21.3 mL vs 77.3 ± 23.0 mL; P < .001) with VesselNavigator compared with control. Procedure time was also shorter with VesselNavigator (80.4 ± 21.2 minutes vs 110.0 ± 29.1 minutes; P = .005).
CONCLUSIONS: Image fusion using VesselNavigator enhances the functionality of conventional fluoroscopy in standard endovascular aneurysm repair. It reduces radiation exposure to patients and providers. It also limits the amount of contrast agent and shortens the overall procedure length. The benefit of this technology is demonstrated on this typically straightforward procedure but may be even more useful for complex procedures.
Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26070603     DOI: 10.1016/j.jvs.2015.03.041

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  12 in total

1.  Novel Three-Dimensional Image Fusion Software to Facilitate Guidance of Complex Cardiac Catheterization : 3D image fusion for interventions in CHD.

Authors:  Sebastian Goreczny; Pawel Dryzek; Gareth J Morgan; Maciej Lukaszewski; Jadwiga A Moll; Tomasz Moszura
Journal:  Pediatr Cardiol       Date:  2017-05-27       Impact factor: 1.655

2.  Select type I and type III endoleaks at the completion of fenestrated endovascular aneurysm repair resolve spontaneously.

Authors:  Nicholas J Swerdlow; John C McCallum; Patric Liang; Chun Li; Thomas F X O'Donnell; Rens R B Varkevisser; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2018-12-21       Impact factor: 4.268

3.  Improving the cardiac cath-lab interventional imaging eco-system.

Authors:  Benjamin R Ciske; Michael A Speidel; Amish N Raval
Journal:  Transl Pediatr       Date:  2018-01

4.  Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm.

Authors:  Min Sun; Liqing Kang; Yanchao Cui; Guoce Li
Journal:  Exp Ther Med       Date:  2018-06-22       Impact factor: 2.447

5.  Dynamic coronary roadmapping during percutaneous coronary intervention: a feasibility study.

Authors:  Kerstin Piayda; Laura Kleinebrecht; Shazia Afzal; Roland Bullens; Iris Ter Horst; Amin Polzin; Verena Veulemans; Lisa Dannenberg; Anna Christina Wimmer; Christian Jung; Florian Bönner; Malte Kelm; Katharina Hellhammer; Tobias Zeus
Journal:  Eur J Med Res       Date:  2018-07-31       Impact factor: 2.175

6.  Three-dimensional image fusion guidance of percutaneous pulmonary valve implantation to reduce radiation exposure and contrast dose: A comparison with traditional two-dimensional and three-dimensional rotational angiographic guidance.

Authors:  S Goreczny; T Moszura; P Dryzek; M Lukaszewski; A Krawczuk; J Moll; G J Morgan
Journal:  Neth Heart J       Date:  2017-02       Impact factor: 2.380

7.  Fluoroscopy with MRA fusion image guidance in endovascular iliac artery interventions: study protocol for a randomized controlled trial (3DMR-Iliac-roadmapping study).

Authors:  Seline R Goudeketting; Stefan G H Heinen; Michiel W de Haan; Anna M Sailer; Daniel A F van den Heuvel; Marco J van Strijen; Jean-Paul P M de Vries
Journal:  Trials       Date:  2018-11-01       Impact factor: 2.279

8.  Magnetic resonance and computed tomography imaging fusion for live guidance of percutaneous pulmonary valve implantation.

Authors:  Sebastian Góreczny; Paweł Dryżek; Tomasz Moszura; Maciej Łukaszewski; Michał Podgórski; Sarah Nordmeyer; Titus Kuehne; Felix Berger; Stephan Schubert
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-12-11       Impact factor: 1.426

9.  Three cases of fusion imaging in endovascular treatment of occlusive peripheral artery disease.

Authors:  Makoto Haga; Takayori Shimizu; Ayako Nishiyama; Shunya Shindo
Journal:  J Vasc Surg Cases Innov Tech       Date:  2019-10-05

10.  Image Fusion During Standard and Complex Endovascular Aortic Repair, to Fuse or Not to Fuse? A Meta-analysis and Additional Data From a Single-Center Retrospective Cohort.

Authors:  Sabrina A N Doelare; Stefan P M Smorenburg; Theodorus G van Schaik; Jan D Blankensteijn; Willem Wisselink; Johanna H Nederhoed; Rutger J Lely; Arjan W J Hoksbergen; Kak Khee Yeung
Journal:  J Endovasc Ther       Date:  2020-09-23       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.